BNET Industries

International Fight League Inc.

(IFLI) is in the Pharma Industry

Market Cap:$395.2K
Last Fiscal Year Sales:$5.6M
  • Public
  • US
Dow Jones Description

Since 2001, Paligent Inc. together with its subsidiaries (collectively, ?Paligent? or the ?Company?) has been engaged in seeking business opportunities to maximize value for its shareholders. The Company has evaluated various strategic alternatives, including acquisitions of new operating businesses and technologies as well as potential merger opportunities. From its inception in 1985 through 1999, the Company operated, under the name Procept, Inc., as a biotechnology company engaged in the development and commercialization of novel drugs with a product portfolio focused on infectious diseases and oncology. During 1999, the Company?s principal efforts were devoted to drug development and human clinical trials focusing on two biotechnology compounds, PRO 2000 Gel and O6-Benzylguanine (?O6-BG?). During fiscal 2000, the Company closed its research facilities and out-licensed PRO 2000 Gel and O6-BG, which had been under development by the Company for several years. In September 2004, the Company transferred all of its rights, title and interest in PRO 2000 Gel pursuant to an option duly exercised by its sublicensee and in March 2005, the Company assigned all of its rights, interests and obligations in O6-BG.

Contact Information

424 West 33rd Street, Suite 650

New York, New York 10001

212- 356-4000

NAICS Code Biological Product (except Diagnostic) Manufacturing: 325414

Decision Makers

Name (plus bio) Position
Jeffrey M. Jagid Director
Zola P. Horovitz Director

Board of Directors

Name (plus bio) Position
Richard J. Kurtz Member of the Board of Directors

Organization Position Status
Ezwebadministration.Com Chairman of the Board, Chief Executive Officer, and Director. Current
I.D. Systems, Inc. Chairman and Chief Executive Officer Current
Coining Technologies, Inc. Director Current
International Fight League, Inc. Director Current
Tannenbaum Helpern Syracuse & Hirschtritt Llp Corporate Litigation Associate Former
I.D. Systems, Inc. Director Former
Benjamin N. Cardozo School of Law Juris Doctor Degree Former
Emory University Bachelor of Business Administration Former

Mr. Kurtz has been chief executive officer of the Kamson Corporation, a privately held corporation, for the past 30 years. The Kamson Corporation has its principal executive offices located in Englewood Cliffs, New Jersey and currently owns and operates eighty one (81) investment properties in the Northeastern U.S. Mr. Kurtz is a graduate of the University of Miami and a member of its President's Club. Most notably, the Chamber of Commerce in Englewood Cliffs and the Boy Scouts of America chose him Man of the Year. Mr. Kurtz resides in Alpine, New Jersey and is currently vice president and a member of the Board of Directors for the Jewish Community Center on the Palisades in Tenafly, New Jersey. He is also an elected member of the Board of Trustees and Foundation Board for the Englewood Hospital and Medical Center of New Jersey and the Board of Governors for the Jewish Home and Rehabilitation Center.

Organization Position Status
Kamson Corporation Chief Executive Officer Current
Lapolla Industries, Inc. Chairman of the Board Current
International Fight League, Inc. Member of the Board of Directors Current
University of Miami President Former
University of Miami Member Former

Organization Position Status
Sage Healthcare, Ltd. Current
Phyton, Inc. Chairman Current
GenVec, Inc. Chairman Current
Immunicon Corporation Chair Current
Genaera Corporation Chairman Current
BioCryst Pharmaceuticals, Inc. Director, Chairman of The Board Current
Xintria Pharmaceutical Corporation Member of Dov Pharmaceuticals Board of Directors Current
Palatin Technologies Inc. Board of Directors Current
Avigen, Inc. Director Current
BioCryst Pharmaceuticals, Inc. Director Current
NitroMed, Inc. Director Current
International Fight League, Inc. Director Current
DOV Pharmaceutical, Inc. Director Current
Immunicon Corporation Director Current
NitroMed, Inc. Committee Member Current
Avigen, Inc. Vice President, Business Development Former
Bristol-Myers Squibb Company Vice President, Business Development and Planning Former
Bristol-Myers Squibb Company Associate Director Former
Bristol-Myers Squibb Company Liaison Former
Phyton, Inc. Director Former
Princeton University Board of Directors Former
GenVec, Inc. Director Former
University of Pittsburgh Ph.D. In Pharmacology Former
University of Pittsburgh M.S. In Pharmacology Former
University of Pittsburgh B.S. In Pharmacy Former
advertisement
     IFLI $0.01 -0.00 (-37.50% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 113,247
Shares Outstanding 79.06M
Market Cap 395.3K
Year High 0.017
Year Low 0.002
Earnings Per Share -0.05
P/E Ratio -0.10
Dividend N/A
Yield N/A
IndustryTop Rated
advertisement